APA

Foody J. M., Toth P. P., Tomassini J. E., Sajjan S., Ramey D. R., Neff D., Tershakovec A. M., Hu H. & Tunceli K. (20140617). Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. : Vascular health and risk management.

Chicago

Foody JoAnne M, Toth Peter P, Tomassini Joanne E, Sajjan Shiva, Ramey Dena R, Neff David, Tershakovec Andrew M, Hu Henry and Tunceli Kaan. 20140617. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. : Vascular health and risk management.

Harvard

Foody J. M., Toth P. P., Tomassini J. E., Sajjan S., Ramey D. R., Neff D., Tershakovec A. M., Hu H. and Tunceli K. (20140617). Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. : Vascular health and risk management.

MLA

Foody JoAnne M, Toth Peter P, Tomassini Joanne E, Sajjan Shiva, Ramey Dena R, Neff David, Tershakovec Andrew M, Hu Henry and Tunceli Kaan. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. : Vascular health and risk management. 20140617.